Loading…
CIK 0001587114 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ecor1-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AKTIS ONCOLOGY INC | COM ADDED | $86.3M | 3.7% | 4,824,469 SH | New |
| ANAPTYSBIO INC | COM | $437.0M | 18.5%Prev: 8.7% | 7,880,094 SH | Increased |
| ATARA BIOTHERAPEUTICS INC | COM NEW | $471K | 0.0%Prev: 0.2% | 99,593 SH | Decreased-473,590 SH |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $25.3M | 1.1% | 2,823,126 SH | New |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $254.6M | 10.8% | 6,410,800 SH | New |
| CG ONCOLOGY INC | COM | $74.6M | 3.2% | 1,102,000 SH | New |
| CRINETICS PHARMACEUTICALS IN | COM | $155.7M | 6.6%Prev: 8.5% | 4,288,120 SH | Increased |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $66.1M | 2.8%Prev: 2.8% | 1,389,276 SH | Increased |
| EIKON THERAPEUTICS INC | COM ADDED | $7.8M | 0.3% | 732,606 SH | New |
| ERASCA INC | COM | $14.6M | 0.6% | 900,000 SH | New |
| ETON PHARMACEUTICALS INC | COM | $53.6M | 2.3%Prev: 1.5% | 2,171,938 SH | Increased+182,150 SH |
| GALAPAGOS NV | SPON ADR | $50.0M | 2.1%Prev: 0.2% | 1,667,119 SH | Increased+1,512,113 SH |
| HELIX ACQUISITION CORP III USD | CL A ORD SHS ADDED | $2.0M | 0.1% | 200,000 SH | New |
| IBIO INC | COM NEW | $3.0M | 0.1% | 1,583,000 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $322.6M | 13.7%Prev: 12.6% | 1,706,469 SH | Increased |
| MBX BIOSCIENCES INC | COM | $23.2M | 1.0%Prev: 0.6% | 777,000 SH | Increased-482,273 SH |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | $4.4M | 0.2% | 13,368,855 SH | New |
| NEUROGENE INC | COM | $25.6M | 1.1%Prev: 0.9% | 1,271,342 SH | Increased |
| ORIC PHARMACEUTICALS INC | COM | $85.2M | 3.6%Prev: 1.1% | 6,728,116 SH | Increased+3,310,048 SH |
| PHATHOM PHARMACEUTICALS INC | COM | $6.9M | 0.3% | 625,000 SH | New |
| PRELUDE THERAPEUTICS INC | COM | $3.2M | 0.1% | 947,049 SH | New |
| RELAY THERAPEUTICS INC | COM | $19.0M | 0.8%Prev: 0.1% | 1,904,762 SH | Increased+1,263,336 SH |
| REPLIMUNE GROUP INC | COM | $7.7M | 0.3%Prev: 0.5% | 1,000,000 SH | Decreased+149,659 SH |
| STOKE THERAPEUTICS INC | COM | $3.3M | 0.1% | 100,000 SH | New |
| SURROZEN INC | *W EXP 08/01/203 | $129K | 0.0%Prev: 0.0% | 4,444 SH | Decreased-62,221 SH |
| XENCOR INC | COM | $26.3M | 1.1%Prev: 3.9% | 2,183,000 SH | Decreased-3,961,767 SH |
| ZENAS BIOPHARMA INC | COM | $15.4M | 0.7% | 789,500 SH | New |
| ZURA BIO LTD | CLASS A ORD SHS | $7.0M | 0.3% | 1,179,715 SH | New |
| ZYMEWORKS INC | COM | $575.2M | 24.4%Prev: 12.2% | 22,970,388 SH | Increased+5,710,840 SH |
| 13F-HR |
| 0000935836-26-000415 |
| $2.06B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000935836-25-000506 | $1.69B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000935836-26-000270 | $2.36B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000935836-25-000338 | $1.69B | View |